Literature DB >> 22289198

Implication of the VGF-derived peptide TLQP-21 in mouse acute and chronic stress responses.

M Razzoli1, E Bo, T Pascucci, F Pavone, F R D'Amato, C Cero, V Sanghez, H Dadomo, P Palanza, S Parmigiani, G Ceresini, S Puglisi-Allegra, M Porta, G C Panzica, A Moles, R Possenti, A Bartolomucci.   

Abstract

The impact of stress is widely recognized in the etiology of multiple disorders. In particular, psychological stress may increase the risk of cardiovascular, metabolic, immune, and mood disorders. Several genes are considered potential candidates to account for the deleterious consequences of stress and recent data point to role of Vgf. VGF mRNA is abundantly expressed in the hypothalamus, where it has been involved in metabolism and energy homeostasis; more recently a link between VGF-derived peptides and mood disorders has been highlighted. The following experiments were performed to address the contribution of the VGF-system to stress induced changes in mice: the distribution of VGF immuno-reactivity in hypothalamic nuclei and its modulation by social stress; the role of VGF-derived peptide TLQP-21 in plasma catecholamine release induced by acute restraint stress (RS); the efficacy of chronic TLQP-21 in a mouse model of chronic subordination stress (CSS). VGF fibers were found in high density in arcuate, dorsomedial, and suprachiasmatic and, at lower density, in lateral, paraventricular, and ventromedial hypothalamic nuclei. Central administration of either 2 or 4 mM TLQP-21 acutely altered the biphasic serum epinephrine release and decreased norepinephrine serum levels in response to RS. Finally, 28-day of 40 μg/day TLQP-21 treatment increased CSS-induced social avoidance of an unfamiliar conspecific. Overall these data support a role for TLQP-21 in stress responses providing a promising starting point to further elucidate its role as a player in stress-related human pathologies.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22289198     DOI: 10.1016/j.bbr.2012.01.038

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  11 in total

1.  Identification of the C3a receptor (C3AR1) as the target of the VGF-derived peptide TLQP-21 in rodent cells.

Authors:  Sebastien Hannedouche; Valerie Beck; Juliet Leighton-Davies; Martin Beibel; Guglielmo Roma; Edward J Oakeley; Vincent Lannoy; Jerome Bernard; Jacques Hamon; Samuel Barbieri; Inga Preuss; Marie-Christine Lasbennes; Andreas W Sailer; Thomas Suply; Klaus Seuwen; Christian N Parker; Frederic Bassilana
Journal:  J Biol Chem       Date:  2013-08-12       Impact factor: 5.157

2.  Clearance kinetics of the VGF-derived neuropeptide TLQP-21.

Authors:  ZengKui Guo; Bhavani S Sahu; Rongjun He; Brian Finan; Cheryl Cero; Raffaello Verardi; Maria Razzoli; Gianluigi Veglia; Richard D Di Marchi; John M Miles; Alessandro Bartolomucci
Journal:  Neuropeptides       Date:  2018-06-19       Impact factor: 3.286

3.  The TLQP-21 peptide activates the G-protein-coupled receptor C3aR1 via a folding-upon-binding mechanism.

Authors:  Cheryl Cero; Vitaly V Vostrikov; Raffaello Verardi; Cinzia Severini; Tata Gopinath; Patrick D Braun; Maria F Sassano; Allison Gurney; Bryan L Roth; Lucy Vulchanova; Roberta Possenti; Gianluigi Veglia; Alessandro Bartolomucci
Journal:  Structure       Date:  2014-11-13       Impact factor: 5.006

4.  Antidepressant-like effects of the phosphodiesterase-4 inhibitor etazolate and phosphodiesterase-5 inhibitor sildenafil via cyclic AMP or cyclic GMP signaling in mice.

Authors:  Chuang Wang; Jianrui Zhang; Yang Lu; Peipei Lin; Tonghe Pan; Xin Zhao; Aiming Liu; Qinwen Wang; Wenhua Zhou; Han-Ting Zhang
Journal:  Metab Brain Dis       Date:  2014-04-05       Impact factor: 3.584

5.  Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells.

Authors:  Laura Molteni; Laura Rizzi; Elena Bresciani; Roberta Possenti; Pamela Petrocchi Passeri; Corrado Ghè; Giampiero Muccioli; Jean-Alain Fehrentz; Pascal Verdié; Jean Martinez; Robert J Omeljaniuk; Giuseppe Biagini; Anna Binda; Ilaria Rivolta; Vittorio Locatelli; Antonio Torsello
Journal:  Front Pharmacol       Date:  2017-03-30       Impact factor: 5.810

6.  The human VGF-derived bioactive peptide TLQP-21 binds heat shock 71 kDa protein 8 (HSPA8)on the surface of SH-SY5Y cells.

Authors:  Shamim Akhter; Sandipan Chakraborty; Daniela Moutinho; Elia Álvarez-Coiradas; Isaac Rosa; Juan Viñuela; Eduardo Domínguez; Angel García; Jesús R Requena
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

7.  Neuropeptide VGF Promotes Maturation of Hippocampal Dendrites That Is Reduced by Single Nucleotide Polymorphisms.

Authors:  Joseph Behnke; Aneesha Cheedalla; Vatsal Bhatt; Maysa Bhat; Shavonne Teng; Alicia Palmieri; Charles Christian Windon; Smita Thakker-Varia; Janet Alder
Journal:  Int J Mol Sci       Date:  2017-03-11       Impact factor: 5.923

8.  VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.

Authors:  Farida El Gaamouch; Mickael Audrain; Wei-Jye Lin; Noam Beckmann; Cheng Jiang; Siddharth Hariharan; Peter S Heeger; Eric E Schadt; Sam Gandy; Michelle E Ehrlich; Stephen R Salton
Journal:  Mol Neurodegener       Date:  2020-01-10       Impact factor: 14.195

Review 9.  TLQP-21, A VGF-Derived Peptide Endowed of Endocrine and Extraendocrine Properties: Focus on In Vitro Calcium Signaling.

Authors:  Elena Bresciani; Roberta Possenti; Silvia Coco; Laura Rizzi; Ramona Meanti; Laura Molteni; Vittorio Locatelli; Antonio Torsello
Journal:  Int J Mol Sci       Date:  2019-12-24       Impact factor: 5.923

10.  VGF changes during the estrous cycle: a novel endocrine role for TLQP peptides?

Authors:  Barbara Noli; Carla Brancia; Filomena D'Amato; Gian-Luca Ferri; Cristina Cocco
Journal:  PLoS One       Date:  2014-10-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.